Tower Research Capital LLC (Trc) Palatin Technologies Inc Transaction History

Tower Research Capital LLC (Trc)

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$0.48 - $0.72 $142 - $213	-297 Reduced 13.86%	1,846 $1,000
Q1 2021 May 17, 2021	SELL	$0.68 - $1.25 $77,129 - $141,781	-113,425 Reduced 98.15%	2,143 $1,000
Q4 2020 Feb 16, 2021	BUY	$0.38 - $0.78 $43,214 - $88,703	113,722 Added 6160.46%	115,568 $78,000
Q3 2020 Nov 16, 2020	SELL	$0.47 - $0.64 $36,052 - $49,093	-76,708 Reduced 97.65%	1,846 $1,000
Q2 2020 Aug 13, 2020	BUY	$0.41 - $0.73 $26,007 - $46,306	63,433 Added 419.5%	78,554 $40,000
Q1 2020 May 15, 2020	BUY	$0.36 - $0.79 $4,779 - $10,487	13,275 Added 719.12%	15,121 $7,000
Q4 2019 Feb 07, 2020	SELL	$0.75 - $0.89 $13,167 - $15,624	-17,556 Reduced 90.49%	1,846 $1,000
Q3 2019 Nov 05, 2019	BUY	$0.78 - $1.09 $13,693 - $19,136	17,556 Added 951.03%	19,402 $18,000
Q2 2019 Aug 13, 2019	SELL	$0.98 - $1.64 $33,512 - $56,081	-34,196 Reduced 94.88%	1,846 $2,000
Q1 2019 May 14, 2019	BUY	$0.67 - $1.01 $6,282 - $9,470	9,377 Added 35.17%	36,042 $35,000
Q4 2018 Feb 14, 2019	BUY	$0.63 - $1.0 $16,798 - $26,665	26,665 New	26,665 $19,000
Q3 2018 Nov 13, 2018	SELL	$0.88 - $1.1 $28,836 - $36,045	-32,769 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$0.91 - $1.45 $29,819 - $47,515	32,769 New	32,769 $32,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.27M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.